Silicon Laboratories Inc
NASDAQ:SLAB
Balance Sheet
Balance Sheet Decomposition
Silicon Laboratories Inc
Current Assets | 646.1m |
Cash & Short-Term Investments | 332.7m |
Receivables | 32.6m |
Other Current Assets | 280.8m |
Non-Current Assets | 698m |
PP&E | 142.2m |
Intangibles | 429.8m |
Other Non-Current Assets | 126m |
Current Liabilities | 111.4m |
Accounts Payable | 44.6m |
Other Current Liabilities | 66.8m |
Non-Current Liabilities | 67.2m |
Other Non-Current Liabilities | 67.2m |
Balance Sheet
Silicon Laboratories Inc
Jan-2015 | Jan-2016 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Jan-2021 | Jan-2022 | Dec-2022 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
142
|
114
|
141
|
269
|
197
|
227
|
203
|
1 075
|
500
|
228
|
|
Cash Equivalents |
142
|
114
|
141
|
269
|
197
|
227
|
203
|
1 075
|
500
|
228
|
|
Short-Term Investments |
194
|
129
|
154
|
495
|
417
|
499
|
522
|
965
|
692
|
212
|
|
Total Receivables |
70
|
74
|
74
|
71
|
73
|
76
|
95
|
98
|
71
|
29
|
|
Accounts Receivables |
70
|
74
|
74
|
71
|
73
|
76
|
95
|
98
|
71
|
29
|
|
Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Inventory |
53
|
54
|
60
|
73
|
75
|
73
|
67
|
49
|
100
|
194
|
|
Other Current Assets |
70
|
53
|
62
|
39
|
65
|
69
|
89
|
52
|
98
|
75
|
|
Total Current Assets |
529
|
423
|
491
|
948
|
827
|
944
|
976
|
2 239
|
1 461
|
738
|
|
PP&E Net |
133
|
131
|
130
|
128
|
139
|
136
|
168
|
174
|
177
|
173
|
|
PP&E Gross |
133
|
131
|
130
|
128
|
139
|
136
|
168
|
174
|
177
|
173
|
|
Accumulated Depreciation |
77
|
86
|
98
|
106
|
119
|
129
|
139
|
121
|
139
|
153
|
|
Intangible Assets |
115
|
121
|
104
|
83
|
171
|
134
|
166
|
119
|
85
|
60
|
|
Goodwill |
229
|
273
|
276
|
288
|
397
|
398
|
632
|
376
|
376
|
376
|
|
Long-Term Investments |
7
|
7
|
5
|
0
|
0
|
0
|
0
|
24
|
28
|
0
|
|
Other Long-Term Assets |
30
|
56
|
77
|
88
|
91
|
62
|
52
|
26
|
43
|
97
|
|
Other Assets |
229
|
273
|
276
|
288
|
397
|
398
|
632
|
376
|
376
|
376
|
|
Total Assets |
1 043
N/A
|
1 012
-3%
|
1 082
+7%
|
1 535
+42%
|
1 624
+6%
|
1 675
+3%
|
1 994
+19%
|
2 958
+48%
|
2 169
-27%
|
1 443
-33%
|
|
Liabilities | |||||||||||
Accounts Payable |
39
|
42
|
40
|
39
|
41
|
39
|
55
|
47
|
90
|
57
|
|
Accrued Liabilities |
49
|
27
|
29
|
42
|
49
|
46
|
47
|
42
|
50
|
24
|
|
Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
45
|
|
Current Portion of Long-Term Debt |
10
|
10
|
0
|
0
|
0
|
0
|
135
|
451
|
0
|
0
|
|
Other Current Liabilities |
66
|
63
|
71
|
82
|
55
|
53
|
48
|
129
|
46
|
37
|
|
Total Current Liabilities |
163
|
142
|
140
|
162
|
145
|
138
|
285
|
669
|
186
|
164
|
|
Long-Term Debt |
78
|
68
|
73
|
342
|
355
|
368
|
429
|
0
|
530
|
0
|
|
Deferred Income Tax |
0
|
14
|
13
|
10
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Liabilities |
44
|
27
|
30
|
68
|
57
|
54
|
80
|
77
|
49
|
71
|
|
Total Liabilities |
285
N/A
|
250
-12%
|
255
+2%
|
582
+128%
|
557
-4%
|
560
+0%
|
794
+42%
|
746
-6%
|
764
+2%
|
234
-69%
|
|
Equity | |||||||||||
Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Retained Earnings |
729
|
748
|
802
|
851
|
961
|
981
|
994
|
2 215
|
1 416
|
1 193
|
|
Additional Paid In Capital |
30
|
14
|
25
|
103
|
108
|
134
|
204
|
0
|
0
|
17
|
|
Unrealized Security Profit/Loss |
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Equity |
0
|
0
|
0
|
1
|
2
|
1
|
2
|
2
|
11
|
1
|
|
Total Equity |
758
N/A
|
761
+0%
|
827
+9%
|
953
+15%
|
1 067
+12%
|
1 115
+4%
|
1 200
+8%
|
2 212
+84%
|
1 405
-36%
|
1 209
-14%
|
|
Total Liabilities & Equity |
1 043
N/A
|
1 012
-3%
|
1 082
+7%
|
1 535
+42%
|
1 624
+6%
|
1 675
+3%
|
1 994
+19%
|
2 958
+48%
|
2 169
-27%
|
1 443
-33%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
42
|
42
|
42
|
43
|
43
|
44
|
44
|
39
|
32
|
32
|